Search Results - Loupy, Alexandre
- Showing 1 - 20 results of 44
- Go to Next Page
-
1
Authors’ Reply by Reese, Peter. P., Aubert, Olivier, Loupy, Alexandre
Published 2021Text -
2
-
3
-
4
-
5
Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes by Reeve, Jeff, Böhmig, Georg A., Eskandary, Farsad, Einecke, Gunilla, Lefaucheur, Carmen, Loupy, Alexandre, Halloran, Philip F.
Published 2017Text -
6
Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival by See, Sarah B., Aubert, Olivier, Loupy, Alexandre, Veras, Yokarla, Lebreton, Xavier, Gao, Baoshan, Legendre, Christophe, Anglicheau, Dany, Zorn, Emmanuel
Published 2018Text -
7
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation by Lefaucheur, Carmen, Loupy, Alexandre, Hill, Gary S., Andrade, Joao, Nochy, Dominique, Antoine, Corinne, Gautreau, Chantal, Charron, Dominique, Glotz, Denis, Suberbielle-Boissel, Caroline
Published 2010Text -
8
Tissue Compartment Analysis for Biomarker Discovery by Gene Expression Profiling by Disset, Antoine, Cheval, Lydie, Soutourina, Olga, Duong Van Huyen, Jean-Paul, Li, Guorong, Genin, Christian, Tostain, Jacques, Loupy, Alexandre, Doucet, Alain, Rajerison, Rabary
Published 2009Text -
9
Donor-Specific Antibodies Accelerate Arteriosclerosis after Kidney Transplantation by Hill, Gary S., Nochy, Dominique, Bruneval, Patrick, van Huyen, J. P. Duong, Glotz, Denis, Suberbielle, Caroline, Zuber, Julien, Anglicheau, Dany, Empana, Jean-Philippe, Legendre, Christophe, Loupy, Alexandre
Published 2011Text -
10
Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients by Aubert, Olivier, Loupy, Alexandre, Hidalgo, Luis, Duong van Huyen, Jean-Paul, Higgins, Sarah, Viglietti, Denis, Jouven, Xavier, Glotz, Denis, Legendre, Christophe, Lefaucheur, Carmen, Halloran, Philip F.
Published 2017Text -
11
Value of Donor–Specific Anti–HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss by Viglietti, Denis, Loupy, Alexandre, Vernerey, Dewi, Bentlejewski, Carol, Gosset, Clément, Aubert, Olivier, Duong van Huyen, Jean-Paul, Jouven, Xavier, Legendre, Christophe, Glotz, Denis, Zeevi, Adriana, Lefaucheur, Carmen
Published 2017Text -
12
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation by Naesens, Maarten, Loupy, Alexandre, Hilbrands, Luuk, Oberbauer, Rainer, Bellini, Maria Irene, Glotz, Denis, Grinyó, Josep, Heemann, Uwe, Jochmans, Ina, Pengel, Liset, Reinders, Marlies, Schneeberger, Stefan, Budde, Klemens
Published 2022Text -
13
Surrogate Endpoints for Late Kidney Transplantation Failure by Naesens, Maarten, Budde, Klemens, Hilbrands, Luuk, Oberbauer, Rainer, Bellini, Maria Irene, Glotz, Denis, Grinyó, Josep, Heemann, Uwe, Jochmans, Ina, Pengel, Liset, Reinders, Marlies, Schneeberger, Stefan, Loupy, Alexandre
Published 2022Text -
14
High-Dosage Intravenous Immunoglobulin–Associated Macrovacuoles Are Associated with Chronic Tubulointerstitial Lesion Worsening in Renal Transplant Recipients by Bollée, Guillaume, Anglicheau, Dany, Loupy, Alexandre, Zuber, Julien, Patey, Natacha, Gregor, Duncan Mac, Martinez, Frank, Mamzer-Bruneel, Marie-France, Snanoudj, Renaud, Thervet, Eric, Legendre, Christophe, Noël, Laure-Hélène
Published 2008Text -
15
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection by Viglietti, Denis, Loupy, Alexandre, Aubert, Olivier, Bestard, Oriol, Van Huyen, Jean-Paul Duong, Taupin, Jean-Luc, Glotz, Denis, Legendre, Christophe, Jouven, Xavier, Delahousse, Michel, Kamar, Nassim, Lefaucheur, Carmen
Published 2018Text -
16
Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance by Aubert, Olivier, Reese, Peter P., Audry, Benoit, Bouatou, Yassine, Raynaud, Marc, Viglietti, Denis, Legendre, Christophe, Glotz, Denis, Empana, Jean-Phillipe, Jouven, Xavier, Lefaucheur, Carmen, Jacquelinet, Christian, Loupy, Alexandre
Published 2019Text -
17
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy by El Karoui, Khalil, Hill, Gary S., Karras, Alexandre, Jacquot, Christian, Moulonguet, Luc, Kourilsky, Olivier, Frémeaux-Bacchi, Véronique, Delahousse, Michel, Van Huyen, Jean-Paul Duong, Loupy, Alexandre, Bruneval, Patrick, Nochy, Dominique
Published 2012Text -
18
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study by Aubert, Olivier, Divard, Gillian, Pascual, Julio, Oppenheimer, Federico, Sommerer, Claudia, Citterio, Franco, Tedesco, Helio, Chadban, Steve, Henry, Mitchell, Vincenti, Flavio, Srinivas, Titte, Watarai, Yoshihiko, Legendre, Christophe, Bernhardt, Peter, Loupy, Alexandre
Published 2021Text -
19
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation by Hilbrands, Luuk, Budde, Klemens, Bellini, Maria Irene, Diekmann, Fritz, Furian, Lucrezia, Grinyó, Josep, Heemann, Uwe, Hesselink, Dennis A., Loupy, Alexandre, Oberbauer, Rainer, Pengel, Liset, Reinders, Marlies, Schneeberger, Stefan, Naesens, Maarten
Published 2022Text -
20
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts by Loupy, Alexandre, Vernerey, Dewi, Tinel, Claire, Aubert, Olivier, Duong van Huyen, Jean-Paul, Rabant, Marion, Verine, Jérôme, Nochy, Dominique, Empana, Jean-Philippe, Martinez, Frank, Glotz, Denis, Jouven, Xavier, Legendre, Christophe, Lefaucheur, Carmen
Published 2015Text